Actually MXC along with MMJ has long been a darling of PP publishing, receiving numerous newsletter promotions.
Just wondering if MXC's differentiation advantage in going down the cosmetics pathway in order to gain early revenue streams has been negated/overtaken by the rapid legislative changes pertaining to MM and Stoners, recently enacted here and in Canada.
Seems to me that MMJ is now in the box seat with their grow facility approval in Canada perfectly timed for next years legalization of recreation weed. Thus wouldn't surprise to hear MXC ann a strategic diversifying acquisition in near future to cover this emerging market. Thoughts?
MXC Price at posting:
7.6¢ Sentiment: Hold Disclosure: Held
